Evoke Pharma Inc. (EVOK)
2.79
0.00 (0.00%)
At close: Mar 28, 2025, 3:49 PM
2.78
-0.36%
After-hours: Mar 28, 2025, 05:11 PM EDT
Evoke Pharma Cash Flow Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Net Income | -5,352.2B | -7.79M | -8.22M | -8.54M | -13.15M | -7.13M | -7.57M | -12.23M | -10.75M | -12.12M | -13.25M | -2.84M | -2.02M | -2.4M |
| Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Stock-Based Compensation | 773.12K | 1.13M | 1.46M | 1.88M | 1.63M | 1.37M | 1.54M | 1.82M | 1.71M | 1.5M | 1.1M | 145.97K | 12.51K | 22.7K |
| Other Working Capital | n/a | 1.14M | 505.61K | -4.84M | 112.99K | -116.68K | -78.17K | 24.66K | 554.01K | 98.19K | -287.5K | -789.77K | n/a | n/a |
| Other Non-Cash Items | -106.55B | 129.07K | 37.02K | -75.13K | 1.45M | 1.37M | -433.39K | 1.01M | 56.97K | 43.57K | 65.47K | 112.09K | -3.21K | -3.07K |
| Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | n/a | 1.55M | 132.41K | -5.62M | 4.9M | -10.4K | -518.56K | 687.83K | 277.3K | 77.7K | 579.06K | -461.86K | 258.37K | -511.5K |
| Operating Cash Flow | -5,458.7B | -4.98M | -6.6M | -12.35M | -6.63M | -5.76M | -6.98M | -8.72M | -8.71M | -10.5M | -11.5M | -3.04M | -1.75M | -2.89M |
| Capital Expenditures | n/a | -3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Debt Repayment | n/a | n/a | n/a | n/a | 5.1M | n/a | n/a | n/a | -4.5M | n/a | 1.5M | 2M | 1M | -277.78K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 14,315.9B | -119.3K | -148.99K | -1.27M | 3.93M | n/a | n/a | n/a | n/a | n/a | -82.69K | n/a | n/a | n/a |
| Financial Cash Flow | 14,315.9B | -119.3K | 7.29M | 13.43M | 9.04M | 6.11M | 4.62M | 7.39M | 9.02M | 5.03M | 1.46M | 27.12M | 1M | -277.78K |
| Net Cash Flow | 8,857.2B | -5.1M | 698.99K | 1.08M | 2.41M | 344.83K | -2.36M | -1.33M | 315.92K | -5.46M | -10.04M | 24.08M | -749.86K | -3.17M |
| Free Cash Flow | -5,458.7B | -4.98M | -6.6M | -12.35M | -6.63M | -5.76M | -6.98M | -8.72M | -8.71M | -10.5M | -11.5M | -3.04M | -1.75M | -2.89M |